Excitingly, the inhibition of NFAT1 can ameliorate the deficits of synucleinopathy by redirecting the excessively activated microglia to active healthy microglia through the suppression of neuroinflammation and the restoration of cellular mobility and phagocytosis abilities. Here, NFATC2 is linked to synucleinopathy.